Navigation Links
The Lilly MDR-TB Partnership Provides Unique Model for Fight Against Multidrug-Resistant Tuberculosis in South Africa
Date:11/9/2007

Technology Transfer Creates Sustainable Solution to Treat One of the

World's Oldest and Deadliest Diseases

CAPE TOWN, South Africa, Nov. 9 /PRNewswire-FirstCall/ -- During the annual meeting of the International Union Against Tuberculosis and Lung Disease (IUATLD), The Lilly MDR-TB Partnership brought together experts to highlight the battle against multidrug-resistant tuberculosis (MDR-TB) in South Africa as a model for the work being done by The Partnership around the world. South Africa is one of the highest-burden MDR-TB countries.

The Lilly MDR-TB Partnership -- a public-private initiative of 14 organizations focused on stopping the spread of MDR-TB and ultimately conquering the disease -- is transferring manufacturing know-how to technology partners around the world. The technology transfer partner in South Africa, Aspen Pharmacare, sold its first batch of cycloserine to Botswana in 2006 and is now producing cycloserine in a brand new facility in Port Elizabeth, South Africa, that has a capacity in excess of 4 billion tablets and capsules per year. Cycloserine is a Lilly antibiotic that is instrumental in the treatment of second-line tuberculosis, or MDR-TB.

Aspen has also now begun construction of a facility at the Port Elizabeth site to produce vials of capreomycin, another critical medicine in the fight against second-line tuberculosis, and is expected to produce this medicine at the facility in early 2009. Capreomycin was developed by Eli Lilly and Company several years ago.

"The ability to manufacture cycloserine locally is essential to treating the plight of multidrug resistance in South Africa," said Mr. Stavros Nicolaou, Executive Director of Aspen Pharmacare. "This initiative allows us to directly address this highly contagious disease, which has a tremendous impact on the health of our country and the entire African continent."

Aspen Pharmacare works closely with the World Health Organization
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Lillys CEO Calls for Reform of Nations Drug Safety System
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
8. Lilly Delivers Strong Third-Quarter Results
9. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
10. Eli Lilly and Company Aids California Recovery Effort
11. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...wire/ -- Jon O,Brien, president of Catholics for C...ssage of HR 3962: ,, "Behavior in recent weeks... values. We in the prochoice community stayed true...gles ordinary Americans have making ends meet. The...althcare or have to choose between maintaining the...
(Date:11/8/2009)...self-assurance, research finds , , SUNDA... been right when she told you to sit up straight: ... you feel more confident about your thoughts. ,... gives a good impression to other people," Richard...ofessor at Ohio State University, said in a univer...
(Date:11/8/2009)...wire/ -- Speaker Nancy Pelosi and Democratic leade...sage of H.R. 3962, the Affordable Health Care for ...215. Below are the Speaker,s opening remarks: ,...all from the President of the United States, Barac...the American people. I thank the President for his...
(Date:11/8/2009)...biopharmaceuticals to be available at the Company&... Toronto, ON (PRWEB) November 8, 2...ure Biopharma Inc. today announced that the Compan...eutical grade freeze dryer and expects to make com...able for contract manufacturing of biopharmaceutic...
(Date:11/8/2009)...e is won," said Dr. Charmaine Yoest. ,, WASHIN...of 240-194, the Stupak-Ellsworth-Pitts-Kaptur-Dahl...on mandates and funding in HR 3962 passed on the H... President and CEO Dr. Charmaine Yoest said, "The ...-life Americans across this country who have flood...
Breaking Medicine News(10 mins):Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:Good Posture May Inspire Confidence 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2
...ces may be causing the surface of the earth to sli...erican scientists, which has been published by the...Carlo Doglioni of Rome's La Sapienza University an... into vast plates that slowly shift, producing ear...
...tion from Singapore in search of 'Bigfoot', an ape...een postponed until 21 January 2006. //This has be...aysia. This has been revealed by the Singapore Par...of 20 members to solve it. Three of the creatures,...
...sian market vendor who came into close contact wit... H5N1 strain of the bird flu virus.// Health autho...onfirmed that the 22-year-old man carried the viru... toll in the country will rise to 15. The WHO ...
...released by China's Ministry of Health, the World ...V/AIDS cases prevailing in the country, //is raisi...y quoted, the New York Times reports. A repor...e number of full-blown cases at 75,000. The report...
...h Secretary of Britain is planning to introduce a ...s aimed at reducing long hours of waiting to avail...The new facility will allow the patients to see th... their appointment in big hospitals which does not...
...ficials in India have revealed that the country is...ountry has set itself a target of less than one le...ing the early 1980s, when the Multi Drug Therapy (...er 2005. // At least 11.27 million leprosy c...
Other Medicine News:
(Date:11/6/2009)...., Nov. 6 Philips Respironics appl...l and Prevention (CDC) to raise awareness about an...sufficiency. The CDC,s release of the first-ever g...ces in sleeplessness is a milestone in quantifying...ng-time educator, industry leader and sleep therap...
(Date:11/6/2009)... 6 Ardea Biosciences, In...ed on the development of small-molecule therapeuti...unodeficiency virus (HIV), today reported recent a... quarter and nine months ended September 30, 2009....nh/20091104/ARDEALOGO ) ,, "Since our last quar...
(Date:11/6/2009)...LE PARK, N.C., Nov. 6 Chimerix, In...vailable antiviral therapeutics to address life-th...opment of the company,s lead antiviral compound, C...the Global Health Security Initiative (GHSI). CMX...loped for the treatment of smallpox, as well as ot...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Research Finds New Crop of Breast Cancer Genes 47543 1Research Finds New Crop of Breast Cancer Genes 47543 2New Study Documents High Prevalence of Serious Mental Illnesses Among Nations Jail Populations 47540 1New Study Documents High Prevalence of Serious Mental Illnesses Among Nations Jail Populations 47540 2Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 1Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 2Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 3Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 4Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 5
... Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), a ...developing and commercializing proprietary product...tting, today announced that it will release its,se...pens on Thursday,August 7, 2008., Cadence managem...o,discuss the financial results and provide a clin...
...nalyses Have Conflicting Results -, CHICAGO, July...nking processes among placebo groups in Alzheimer,... to show the effectiveness,of new Alzheimer therap...he,2008 Alzheimer,s Association International Conf...go., Alzheimer clinical trials seek to show that ...
Other Medicine Technology:Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008 2Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 2Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 3Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 4Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 5
PCS®2 System
Elutra Cell Separation System
Plasma Extractor
Multipette
Medicine Products: